The 2025-2026 Ferdinand C. Valentine Fellowship Award application cycle is now open. Applications are due Monday, January 20th.
Background
The New York Academy of Medicine's Ferdinand C. Valentine Fellowship Award for Research in the Field of Urology was established in 1963 to support research training in the specialty of urology for individuals who have completed residency training (prior to the grant award period) acceptable to the American Board of Urology, and who intend to use research training for continued development of an academic career in urology.
Eligibility Requirements
Preference will be given to candidates who will pursue their fellowship at institutions in the greater New York area. Fellows will be required to commit no less than fifty percent of their time to the supported research. First-time applicants will be given preference and only in exceptional circumstances will the renewal of awards be considered. Applicants may apply for both the American Foundation for Urologic Disease and Valentine grants, but if awarded both, candidates may accept only one. Candidates must be United States citizens, permanent residents or have (at the time of application) a valid working visa that can be renewed (if required) through the period of the award.
Application Process
Applicants must complete an online application that requires uploading certain materials and forms:
- A signed cover letter describing previous training and experience and how the proposed activities relate to the applicant’s projected career.
- Your education and research experience (the online application contains a specific form to be uploaded and completed)
- A description of project facilities (the online application contains a specific form to be uploaded and completed)
- A project budget (the online application contains a specific form to be uploaded and completed)
- A description of the applicant's research career goals (the online application contains a specific form to be uploaded and completed)
- A research proposal that includes the project title, applicant’s name, research site, introduction, specific aims, work done by others, work done by applicant, methods of procedure, significance, potential obstacles and relevant bibliography. This should not exceed four (4) pages, including diagrams, illustrations, bibliography and any other supplemental materials.
- A curriculum vitae
- A signed letter of support from applicant's research sponsor detailing your career development plan, providing a description of the research environment and available research facilities to be provided for the proposed project, providing an analysis of your clinical and research training and affirming that the sponsor has evaluated and approved your proposed application
- An NIH biosketch of the research sponsor (sample provided in the online application)
- Documentation of IRB or IACUC protocol approval, proof of submission, or waiver (if applicable). The complete protocol is not required, only the appropriate approval or submission cover page. Approvals for pending protocols must be in place by the start of the grant. In the case of animal research, include a copy of the institution’s current HHS Animal Welfare Assurance approval or renewal letter, or a letter from the institution’s research administration office affirming that the animal facility complies with all federal standards and has been so certified.
- Signed certification letter from your institutional Grants or Finance Office accepting responsibility for overseeing this grant and stating that the official accepts the conditions outlined in the Academy Patent Policy (policy available online for download).
To begin the application process, click on the link below. You will be asked to complete an eligibility quiz. Provided that you meet the program eligibility requirements, you will then be asked to register by creating a login and password. With your login and password, you will be able to access the online application, including the forms that you must upload and complete.
CLICK HERE TO APPLY ONLINE
The application should work in all browsers. We recommend that you use Firefox, Chrome or Internet Explorer.
Award Information
A one-year fellowship award of $50,000 is available for research commencing in July of the application year. The grant is made to the sponsoring institution for the direct support of the salary and research activities of the awardee. Indirect costs and fringe benefits are not paid by this program. Grant recipients are required to submit progress and financial reports to NYAM at the mid-point and end of the grant period. Failure to comply with reporting requirements may result in termination of the grant and refund of any award monies paid, and may negatively affect consideration of future applications from the grantee’s institution. In addition, it is expected that the results of the supported research will be submitted to a peer reviewed journal for publication. For all publications acknowledgment must be made of support from The Ferdinand C. Valentine Fellowship and The New York Academy of Medicine.
Apply Now
Current & Previous Recipients
2023 - 2024
Parwiz Abrahimi, MD, PhD
New York-Presbyterian/Weill Cornell Medical College
Development and optimization of novel cell therapy for bladder cancer
Kavita Gupta, MD
Montefiore Medical Center
Evaluating the Effect of High Power Lasers on Renal Temperature and Renal Injury During Intrarenal Surgery
2021 - 2022
Caroline Kang, MD, PhD
Weill Cornell Medicine
The role of ADCY2 in male infertility due to cryptorchidism
Alan Yaghoubian, MD
Massachusetts General Hospital
Use of Urinary Biomarkers to Quantify Degree of Renal Parenchymal and Urothelial Damage During Ureteroscopy and Percutaneous Nephrolithotomy
Research conducted at Icahn School of Medicine at Mount Sinai
2020-21
Johnathan Khusid, MD
Icahn School of Medicine at Mount Sinai
Clinical Significance of the Kidney Stone Proteome
Siva Venkat, MD
Weill Cornell College of Medicine
Targeting Endoplasmic Reticulum Stress and the Unfolded Protein Response in a Murine Bladder Cancer Model
2019-20
Richard Matulewicz, MD
NYU Langone/Bellevue Hospital
Development and validation of a novel biomarker based nomogram to risk stratify patients undergoing diagnostic evaluation for microscopic hematuria
2018-19
Russell Hayden, MD
Weill Cornell Medicine
The Role of Long Non-Coding RNAs in Male Infertility
Jennifer Reifsnyder, MD
Cohen's Children's Medical Center at Northwell Health
Noninvasive Detection of Potential for Renal Damage in Pediatric Patients with Vesicoureteral Reflux Using Dynamic Range Ultrasonography
2017-2018
Bradley Morgenstern, MD
Feinstein Institute for Medical Research
Dynamic Range Ultrasonography in Pediatric Urologic and Nephrologic Renal Diseases
2015-2016
David Golombos, MD
Weill Cornell Medical College
Mutational Analysis to Predict Prostate Cancer Aggressiveness
2014-2015
Padriac O'Malley, MD
Weill Cornell Medical College
Development of Novel Diagnostic Imaging Applications for Prostate Cancer
2013-2014
Matthew Wosnitzer, MD
Weill Cornell Medical College/NY-Presbyterian Hospital
The Role of Ubiquitin Specific Protease 26 (USP26) in Testicular Function and Male Infertility
2010-2011
Richard K. Lee, MD, MBA
The Joan & Sanford I. Weill Medical College of Cornell University
Nanoparticle-mediated Microwave Thermotherapy for the Treatment of Prostate Cancer
2009-2010
Gerald J. Wang, MD
New York Presbyterian Hospital, Weill Cornell Medical Center<
Applications of multiphoton microscopy in the diagnosis and evaluation of response to immunotherapy in human bladder cancer
2008-2009
Mauricio Davalos, MD
New York Medical College
Oxidative Renal Cell Injury Induced by Calcium Oxalate and Renoprotection with Antioxidants: A Possible Role of Oxidative Stress in Nephrolithiasis
Gerald Y. Tan, MD
Weill Medical College of Cornell University
Novel use of multiphoton microscopy & second-harmonic generation for intra-operative real-time flourescent imaging of peri-prostatic neural architecture during nerve-sparing radical prostatectomy to improve potency outcomes: a controlled study in a rat model
2007-2008
Stephen A. Boorjian, MD
Mayo Clinic
Expression of Inhibitory T Cell Coregulatory Molecules in Primary and Metastic Urothelial Cell Carcinoma of the Bladder
Howard H. Kim, MD
Weill Medical College of Cornell University
Investigation of the Pathophysiology of Leydig Cell Dysfunction and Impaired Spermatogenesis Using a Novel Mouse Varicocele Model
2006-2007
George J. Huang, MD
University of Southern California, Keck School of Medicine
Patterns of Care in Bladder Cancer: Emerging Trends Over Time
2005-2006
Ricardo R. Gonzalez, MD
Weill Medical College of Cornell University
Modulating Bladder Neuroinflammation: Investigating Potential Diagnostics and Therapeutics for Interstitial Cystitis
Richard Lee, MD
Children's Hospital Boston
The Identification of a Urinary Biomarker of Upper Tract Obstruction Using Proteomic Analysis in a Neonatal and Adult Rat Model
2004-2005
Saurabh Agarwal, MD
New York Medical College<
Possible renoprotection against nephrotoxic agents by glutathione in rats: Role of specific glutathione-dependent enzyme
Michael P. Zahalsky, MD, MMS
Laboratory of David C. Page, MD, Whitehead Institute
Department of Biology, Massachusetts Institute of Technology and Howard Hughes Medical Institute
X-Linked Testis Genes and Human Spermatogenic Failure
2003-2004
David Yen Tang Chen, MD
New York Presbyterian-Weill Cornell Medical Center
Characterization of Neutral Endopeptidas - anti-PSMA mAb J591 Fusion Protein and Applications as Therapy for Advanced Prostate Cancer
Jeffrey Michael Donohoe, MD
Vanderbilt University Medical Center
Effects of Specific Angiotensin Receptor Subtype Blockade on Bladder Fibrosis
John Stephen Lam, MD (Honorable Mention)
David Geffen School of Medicine at UCLA
Characterization of Carbonic Anhydrase (CA IX) as a Tumor-Associated Antigen for Target-Directed Vaccine Therapy of Renal Cell Carcinoma
2002-2003
Assad El-Hakim, MD
Long Island Jewish Medical Center
Laparoscopic Bowel Injury: Evaluation of the Immune Response
Rosalia Misseri, MD
Indiana University School of Medicine
Determining the Hydrostatic Threshold for Bladder Injury
2001-2002
Carin V. Hopps, MD
The New York Hospital-Cornell Medical Center
Molecular Investigation of Human Spermatogenesis
Albert A. Samadi, MD
New York Medical College
Mechanism of Cathepsin D Activation and Its Regulation in Prostate Cancer
Douglas S. Scherr, MD
Memorial Sloan-Kettering Cancer Center
The Role of p27 in Prostate Epithelial Cell Proliferation/Differentiation
2000-2001
No Fellowships awarded
1999-2000
Robert Soe-Hliang Lai, MD
Long Island Jewish Medical Center
Electric Neuromodulation in the Treatment of the Neurogenic Bladder Following Spinal Cord Injury
1998-1999
Badrinath R. Konety, MD
University of Pittsburgh Cancer Institute
Molecular Characterization of a Novel Nuclear Matrix Protein Associated with Bladder Cancer
Mark B. Noss, MD, MSc
Albert Einstein College of Medicine and Montefiore Medical Center
Immunogenetic Etiology of Peyronie’s Disease
1997-1998
Gary E. Lemack, MD
University of Texas – Southwestern Medical Center
Lower Urinary Tract Development and Physiology in Mice Lacking Inducible Nitric Oxide Synthase
View our COVID-19 Safety Protocols for attending NYAM public events.